Dermatology

Latest News

Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study
Positive Results for Ruxolitinib Cream in Children with Atopic Dermatitis Presented in Ongoing Study

March 18th 2024

Ruxolitinib cream showed positive results in children 2- to 11-years-old with mild to moderate atopic dermatitis (AD), according to data of a poster presented at the American Academy of Dermatology Annual Meeting in San Diego from March 8 to 12.

sinhyu-stock.adobe.com
Opzelura Provides Benefit in Atopic Dermatitis in Real-World Studies | AAD 2024

March 8th 2024

Reasons for attending the AAD meeting | AAD 2024
Reasons for attending the AAD meeting | AAD 2024

March 7th 2024

Maris-stock.adobe.com
FDA Approves First-in-Class Cell Treatment for Patients With Advanced Melanoma

February 19th 2024

© somartin - stock.adobe.com
Japan Approves Dupixent for Chronic Spontaneous Urticaria (CSU) Becoming First in the World to Do So

February 16th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.